Bharat Immunologicals Statements
52
Bharat Immunologicals Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
76.503
100
139.35
145.9
-62.848
-45.9
—
0
—
0
49.251
38.4
-112.1
-84.3
-37.187
-26.8
23.4
29.2
-125.89
-81.8
-36.117
-25.7
-89.769
-56.1
-2.074
43.273
369.59
100
403.71
107
-34.123
-7
—
0
—
0
39.911
2.6
-74.034
-9.6
-33.226
-6.6
4.631
1.2
-102.63
-15
-21.831
-3.3
-80.797
-11.6
-1.87
43.249
220.41
100
246.4
111.8
-25.999
-11.8
—
0
—
0
10.033
4.6
-36.032
-16.3
-16.693
-7.6
5.12
2.3
-47.605
-21.6
-37.708
-17.1
-9.897
-4.5
-0.213
46.497
174.31
100
121.4
69.7
52.901
30.3
—
0
—
0
43.152
24.8
9.749
5.6
-15.385
-8.8
1.238
0.7
-4.398
-2.5
-1.104
-0.6
-3.294
-1.9
-0.08
41.175
389.17
100
366.98
101.3
22.19
-1.3
—
0
—
0
47.888
13.1
-25.698
-14.4
-23.839
-5
4.666
0.9
-44.871
-18.5
29.474
19.4
-74.345
-37.9
-1.72
42.973
156.24
100
279.7
179
-123.46
-79.02
—
0
—
0
24.423
15.6
-147.89
-94.7
-12.243
-7.8
9.231
5.9
-150.9
-96.6
-35.224
-22.5
-115.67
-74.04
-2.657
43.534
251.99
100
255.82
101.5
-3.832
-1.5
—
0
—
0
19.502
7.7
-23.334
-9.3
-12.961
-5.1
12.003
4.8
-24.292
-9.6
-5.345
-2.1
-18.947
-7.5
-0.44
43.061
445.11
100
421.08
105.4
24.03
-5.4
—
0
—
0
63.906
12.6
-39.876
-18
-22.57
-4.6
-4.442
0.5
-66.888
-22.03
-20.381
-6.8
-46.507
-15.2
-1.077
43.18
517.35
100
449.52
77.1
67.833
22.9
—
0
—
0
47.387
5.2
20.446
17.7
-25.92
-4.2
-8.355
-5.6
-13.829
7.8
-27.974
-8.4
14.145
16.2
0.354
42.813
151.01
100
223.83
157.9
-72.82
-57.9
—
0
—
0
54.078
25.5
-126.9
-83.3
-21.497
-15.4
20.192
2.2
-128.2
-96.6
-11.945
-26.7
-116.26
-69.9
-2.637
44.085
47.589
100
66.293
139.3
-18.704
-39.3
—
0
—
0
39.498
83
-58.202
-122.3
-1.263
-2.7
4.431
9.3
-55.034
-115.6
-16.104
-33.8
-38.93
-81.8
-0.903
43.116